On the one hand, ASPM is a regulator of Wnt and stemness in pancreatic adenocarcinoma [37] which as a Wnt associated marker, it is not only could predict survival time but also could become a target therapy [38]. This evidence concerns the gene ASPM and pancreatic adenocarcinoma.